What's new

Human medicines European public assessment report (EPAR): Atazanavir Krka, atazanavir, Date of authorisation: 25/03/2019, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Atazanavir Krka, atazanavir, Date of authorisation: 25/03/2019, Revision: 3, Status: Authorised

Jun 3, 2025 - 11:00
 0
Human medicines European public assessment report (EPAR): Atazanavir Krka, atazanavir, Date of authorisation: 25/03/2019, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Atazanavir Krka, atazanavir, Date of authorisation: 25/03/2019, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

iVendi and Barbuck join forces to boost dealer finance conversations

Next Article

Human medicines European public assessment report (EPAR): Corbilta (previously L...

Related Posts

Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 3, 2025  0

European Shortages Monitoring Platform (ESMP): Implemen...

May 13, 2025  0

EudraVigilance registration manual

May 23, 2025  0